What Is XORTX Therapeutics Inc. (XRTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, XORTX Therapeutics Inc.'s intrinsic value is estimated at a composite $1.74, showing conflicting signals at the current price of $2.01. While the average implied return is -13.4%, model disagreement is elevated with a gap of +189.5% between the most bullish and bearish estimates. The most optimistic model, ML-RIV, places fair value at $3.98 (+98.0%), while Dynamic NAV — the most conservative — estimates $0.17 (-91.5%). This +189.5% gap reflects genuine analytical uncertainty about XORTX Therapeutics Inc.'s intrinsic worth.
What Do the Models Say About XRTX?
6 of 13 models are currently active for XRTX. Of these, 3 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates XRTX's intrinsic value at $0.58, implying -71.2% downside from the current price. See which stocks rank higher →
How Does XRTX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, XRTX ranks #372 by Quality of Company score. CirclFi's QOC score of 3.5/10 evaluates 32 fundamental signals. A score of 3.5 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to pharmaceutical industry businesses. For XORTX Therapeutics Inc., metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.
Is XRTX a Value Trap?
The Value Trap algorithm is not active for XRTX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for XORTX Therapeutics Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, XORTX Therapeutics Inc. scores 3.5 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +189.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every XRTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across XRTX's 6 active models, average confidence is 12%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad